Herbalife (NYSE:HLF - Get Free Report)'s stock had its "neutral" rating reissued by research analysts at DA Davidson in a research report issued on Thursday,Benzinga reports. They currently have a $7.50 price target on the stock. DA Davidson's price target indicates a potential downside of 13.54% from the stock's previous close.
A number of other brokerages have also recently issued reports on HLF. Mizuho lifted their price objective on Herbalife from $8.00 to $9.00 and gave the company a "neutral" rating in a report on Friday, November 1st. Citigroup cut their price objective on Herbalife from $16.00 to $13.00 and set a "buy" rating for the company in a report on Friday, October 25th. B. Riley cut their price objective on Herbalife from $17.00 to $12.00 and set a "buy" rating for the company in a report on Thursday, October 31st. Finally, StockNews.com raised Herbalife from a "hold" rating to a "buy" rating in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Herbalife has a consensus rating of "Hold" and an average price target of $9.90.
Get Our Latest Stock Report on HLF
Herbalife Stock Up 4.4 %
HLF traded up $0.37 during trading on Thursday, reaching $8.68. 5,200,686 shares of the company's stock were exchanged, compared to its average volume of 2,926,800. Herbalife has a fifty-two week low of $5.04 and a fifty-two week high of $12.79. The business has a 50 day moving average price of $6.32 and a 200 day moving average price of $7.20. The company has a market capitalization of $877.91 million, a P/E ratio of 3.48, a PEG ratio of 0.29 and a beta of 1.15.
Herbalife (NYSE:HLF - Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The company reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.08 by $0.28. The firm had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.19 billion. Herbalife had a net margin of 5.09% and a negative return on equity of 20.78%. As a group, research analysts forecast that Herbalife will post 1.57 EPS for the current year.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in HLF. Arrowstreet Capital Limited Partnership raised its holdings in shares of Herbalife by 777.0% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,987,490 shares of the company's stock valued at $19,986,000 after buying an additional 2,646,848 shares during the last quarter. Jacobs Levy Equity Management Inc. increased its position in Herbalife by 67.0% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 2,570,226 shares of the company's stock worth $17,195,000 after purchasing an additional 1,031,078 shares during the period. Long Focus Capital Management LLC increased its position in Herbalife by 27.3% in the fourth quarter. Long Focus Capital Management LLC now owns 4,758,127 shares of the company's stock worth $31,832,000 after purchasing an additional 1,020,127 shares during the period. Vanguard Group Inc. increased its position in Herbalife by 7.5% in the fourth quarter. Vanguard Group Inc. now owns 11,271,417 shares of the company's stock worth $75,406,000 after purchasing an additional 785,574 shares during the period. Finally, Iridian Asset Management LLC CT increased its position in Herbalife by 43.7% in the third quarter. Iridian Asset Management LLC CT now owns 2,228,193 shares of the company's stock worth $16,021,000 after purchasing an additional 677,739 shares during the period.
About Herbalife
(
Get Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Further Reading
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
